Importance of "targeted therapy" in EGFR-mutated Lung Cancer after Radiochemotherapy

被引：0
|
作者：
Mueller, Joerg Andreas [1 ,2 ]
Vordermark, Dirk [1 ]
机构：
[1] Univ Klin Halle Salle, Klin & Poliklin Strahlentherapie, Ernst Grube Str 40, D-06112 Halle, Saale, Germany
[2] Arbeitsgrp Junge DEGRO Deutsch Gesell Radioonkol e, Berlin, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2024年 / 200卷 / 10期
关键词：
CHEMORADIOTHERAPY; DURVALUMAB; NSCLC;
D O I：
10.1007/s00066-024-02284-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：921 / 923
页数：3
相关论文
共 50 条
  • [41] EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes
    Jin, Rui
    Peng, Ling
    Shou, Jiawei
    Wang, Jin
    Jin, Yin
    Liang, Fei
    Zhao, Jing
    Wu, Mengmeng
    Li, Qin
    Zhang, Bin
    Wu, Xiaoying
    Lan, Fen
    Xia, Lixia
    Yan, Junrong
    Shao, Yang
    Stebbing, Justin
    Shen, Huahao
    Li, Wen
    Xia, Yang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] EGFR-TKIs in EGFR-mutated lung cancer: setting the new standard for 1st line therapy
    Wolf, Juergen
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (01) : 3 - 4
  • [43] Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer
    Moiseyenko, Fedor, V
    Kuligina, Ekaterina S.
    Zhabina, Albina S.
    Belukhin, Sergey A.
    Laidus, Tatiana A.
    Martianov, Aleksandr S.
    Zagorodnev, Kirill A.
    Sokolova, Tatyana N.
    Chuinyshena, Svetlana A.
    Kholmatov, Maxim M.
    Artemieva, Elizaveta, V
    Stepanova, Ekaterina O.
    Shuginova, Tatiana N.
    Volkov, Nikita M.
    Yanus, Grigoriy A.
    Imyanitov, Evgeny N.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 850 - 862
  • [44] Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer
    Fedor V. Moiseyenko
    Ekaterina S. Kuligina
    Albina S. Zhabina
    Sergey A. Belukhin
    Tatiana A. Laidus
    Aleksandr S. Martianov
    Kirill A. Zagorodnev
    Tatyana N. Sokolova
    Svetlana A. Chuinyshena
    Maxim M. Kholmatov
    Elizaveta V. Artemieva
    Ekaterina O. Stepanova
    Tatiana N. Shuginova
    Nikita M. Volkov
    Grigoriy A. Yanus
    Evgeny N. Imyanitov
    International Journal of Clinical Oncology, 2022, 27 : 850 - 862
  • [45] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers
    Vojnic, Morana
    Kubota, Daisuke
    Kurzatkowski, Christopher
    Offin, Michael
    Suzawa, Ken
    Benayed, Ryma
    Schoenfeld, Adam J.
    Plodkowski, Andrew J.
    Poirier, John T.
    Rudin, Charles M.
    Kris, Mark G.
    Rosen, Neal X.
    Yu, Helena A.
    Riely, Gregory J.
    Arcila, Maria E.
    Somwar, Romel
    Ladanyi, Marc
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : 802 - 815
  • [47] Furmonertinib as adjuvant therapy in EGFR-mutated non-small cell lung cancer following radical lung cancer surgery
    Zhang, Q.
    Ke, L.
    Xu, J.
    He, C.
    He, T.
    Zhou, Z.
    Lv, W.
    Hu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1550 - S1550
  • [48] Short-course Immunotherapy Prior to Targeted Therapy in EGFR-Mutated Metastatic Non-Small Cell Lung Cancer: A Retrospective Study
    Chen, P.
    Li, J.
    Feng, Y.
    Liang, W.
    He, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S639 - S639
  • [49] Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy?
    Milano, Michael T.
    Salama, Joseph K.
    Chmura, Steven J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (06): : 605 - 607
  • [50] Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapy
    Meriggi, Fausto
    Codignola, Claudio
    Beretta, Giordano D.
    Ceresoli, Giovanni L.
    Caprioli, Alberto
    Scartozzi, Mario
    Fraccon, Anna P.
    Prochilo, Tiziana
    Ogliosi, Chiara
    Zaniboni, Alberto
    TUMORI JOURNAL, 2017, 103 (05): : 443 - 448
12345